A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance (Q33337302)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q28215761)
(P304) 1221-1229
(P407) (Q1860)
(P433) 5
(P478) 7
(P577) Tuesday, May 1, 2001
(P921) (Q5452194)
(Q643839)
(Q18936)
(Q423762)
(P1433) (Q332253)
(P1476) "A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance" (language: en)
(P2093) R Advani
G A Fisher
B L Lum
J Hausdorff
J Halsey
M Litchman
other details
description scientific article

External Links